adverse effects of glp-1 receptor agonists Clinical Recommendations to Manage Gastrointestinal Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus Gastrointestinal effect and adverse effects

Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.

Learn the critical differences between this FDA-recognized rare sugar and prescription GLP-1 medications for diabetes management and weight loss.

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease

Compare early results with Wegovy and Mounjaro.

Learn how GLP-1 drugs can help you lose weight, which ones are best, and where to get them.

Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D